<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="56251">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02373852</url>
  </required_header>
  <id_info>
    <org_study_id>SVG-CL003</org_study_id>
    <nct_id>NCT02373852</nct_id>
  </id_info>
  <brief_title>PMS Retrospective Study of WIRION Performance in Patients Undergoing Saphenous Vein Graft (SVG) Intervention</brief_title>
  <official_title>Post Marketing Surveillance (PMS) Retrospective Study of WIRION Performance in Patients Undergoing Saphenous Vein Graft (SVG) Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gardia Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gardia Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to collect data on the use of the WIRION system in Patients
      undergoing Percutaneous Intervention of Saphenous Vein Graft (SVG).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      WIRION system is used as protection device in patients undergoing SVG stenting procedure.
      This retrospective study collects data on the usability of the WIRION during the procedure.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Collecting data on the use of the WIRION system in patients undergoing SVG stenting. Collected data includes device performance during procedure and AE/SAE records during procedure and 30 days following procedure.</measure>
    <time_frame>30 Days</time_frame>
    <description>Data collection of WIRION performance</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Stenosis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Saphenous vein graft (SVG) stenting</intervention_name>
    <description>Opening and stenting of blocked SVG with the use of the WIRION embolic protection filter</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients undergoing percutaneous intervention (PI) of saphenous vein graft (SVG) stenting
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients underwent percutaneous intervention (PI) of SVG stenting in which the
             WIRIONTM system was used.

          -  Patient is greater than or equal to 18 years of age.

        Exclusion Criteria:

          -  Undergone cardiac surgery in the past 60 days before the procedure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Uri Rosenschein, MD</last_name>
    <email>uri.rosenschein@b-zion.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bnai Zion</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uri Rosenschein, MD</last_name>
      <email>uri.rosenschein@b-zion.org.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <lastchanged_date>February 22, 2015</lastchanged_date>
  <firstreceived_date>September 22, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
